Pharmagest Interactive Societe Anonyme reported unaudited sales results for the year ended December 31, 2013. For the period, the company's turnover was EUR 113.41 million compared to EUR 108.72 million a year ago.

The structure of the PHARMAGEST Group's turnover in 2013 as well as the 100% integration in fourth quarter of its subsidiary HEALTHLEASE FRANCE makes it possible to anticipate a profit in 2013 as well as profitability that is increasing and greater than projected.

For 2014, the PHARMAGEST Group already expects a significant impact on its Laboratories business as a result of regulatory changes. The decrease in turnover with low profit margin of this activity (Communication services), however, will have a mitigated effect on the operating income of the PHARMAGEST Group.